Literature DB >> 26796758

Predictors of cerebral blood flow in patients with and without anemia.

Matthew T Borzage1, Adam M Bush2, Soyoung Choi3, Aart J Nederveen4, Lena Václavů4, Thomas D Coates5, John C Wood6.   

Abstract

Sickle cell disease (SCD) is the most common cause of stroke in childhood and results primarily from a mismatch of cerebral oxygen supply and demand rather than arterial obstruction. However, resting cerebral blood flow (CBF) has not been examined in the general African American population, in whom obesity, hypertension, cerebrovascular disease, and diminished cerebrovascular reserve capacity are common. To better understand the underlying physiological substrate upon which SCD is superimposed, we measured CBF in 32 young (age 28 ± 10 yr), asymptomatic African American subjects with and without sickle cell trait (n= 14). To characterize the effects of chronic anemia, in isolation of sickle hemoglobin we also studied a cohort of 13 subjects with thalassemia major (n= 10), dyserythropoetic anemia (n= 1), or spherocytosis (n= 2). Blood was analyzed for complete blood count, hemoglobin electrophoresis, cell free hemoglobin, and lactate dehydrogenase. Multivariate regression analysis showed that oxygen content was the strongest predictor of CBF (r(2)= 0.33,P< 0.001). CBF declined rapidly in the second and third decades of life, but this drop was explained by reductions in cerebral gray matter. However, age effects persisted after correction for brain composition, possibly representing microvascular impairment. CBF was independent of viscosity, hemoglobin S%, and body mass index. Hyperoxia resulted in reduced CBF by 12.6% (P= 0.0002), and CBF changes were proportional to baseline oxygen content (r(2)= 0.16,P= 0.02). These data suggest that these hemoglobin subtypes do not alter the normal CBF regulation of the balance of oxygen supply and demand.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  African Americans; anemia; cerebral blood flow; hyperoxia; stroke

Mesh:

Substances:

Year:  2016        PMID: 26796758      PMCID: PMC4835904          DOI: 10.1152/japplphysiol.00994.2015

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  33 in total

Review 1.  Cerebrovascular disease in African Americans.

Authors:  P B Gorelick
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

2.  Fundamental importance of arterial oxygen content in the regulation of cerebral blood flow in man.

Authors:  M M Brown; J P Wade; J Marshall
Journal:  Brain       Date:  1985-03       Impact factor: 13.501

3.  Regulation of cerebral blood flow in response to changes in blood viscosity.

Authors:  M M Brown; J Marshall
Journal:  Lancet       Date:  1985-03-16       Impact factor: 79.321

Review 4.  A small step for the cell, a giant leap for mankind: a hypothesis of neocortical expansion during evolution.

Authors:  P Rakic
Journal:  Trends Neurosci       Date:  1995-09       Impact factor: 13.837

5.  Cerebral blood flow changes in benign aging and cerebrovascular disease.

Authors:  T G Shaw; K F Mortel; J S Meyer; R L Rogers; J Hardenberg; M M Cutaia
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights.

Authors:  A S Dekaban
Journal:  Ann Neurol       Date:  1978-10       Impact factor: 10.422

7.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

8.  Regional cerebral blood flow and oxygen consumption in human aging.

Authors:  P Pantano; J C Baron; P Lebrun-Grandié; N Duquesnoy; M G Bousser; D Comar
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

9.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

Review 10.  Cerebrovascular disorders in children.

Authors:  John Kylan Lynch
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

View more
  25 in total

Review 1.  Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease.

Authors:  Kristin P Guilliams; Melanie E Fields; Michael M Dowling
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

2.  Pseudo continuous arterial spin labeling quantification in anemic subjects with hyperemic cerebral blood flow.

Authors:  Adam Bush; Yaqiong Chai; So Young Choi; Lena Vaclavu; Scott Holland; Aart Nederveen; Thomas Coates; John Wood
Journal:  Magn Reson Imaging       Date:  2017-12-09       Impact factor: 2.546

3.  White matter has impaired resting oxygen delivery in sickle cell patients.

Authors:  Yaqiong Chai; Adam M Bush; Julie Coloigner; Aart J Nederveen; Benita Tamrazi; Chau Vu; Soyoung Choi; Thomas D Coates; Natasha Lepore; John C Wood
Journal:  Am J Hematol       Date:  2019-02-21       Impact factor: 10.047

4.  A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.

Authors:  Shuai Yuan; Lori C Jordan; Larry T Davis; Petrice M Cogswell; Chelsea A Lee; Niral J Patel; Spencer L Waddle; Meher Juttukonda; R Sky Jones; Allison Griffin; Manus J Donahue
Journal:  Br J Haematol       Date:  2020-12-16       Impact factor: 6.998

5.  Anemia predicts lower white matter volume and cognitive performance in sickle and non-sickle cell anemia syndrome.

Authors:  Soyoung Choi; Sharon H O'Neil; Anand A Joshi; Jian Li; Adam M Bush; Thomas D Coates; Richard M Leahy; John C Wood
Journal:  Am J Hematol       Date:  2019-07-23       Impact factor: 10.047

6.  Sickle cell microvascular paradox-oxygen supply-demand mismatch.

Authors:  Jon A Detterich; Roberta Kato; Adam Bush; Patjanaporn Chalacheva; Derek Ponce; Madushka De Zoysa; Payal Shah; Michael C Khoo; Herbert J Meiselman; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2019-04-19       Impact factor: 10.047

7.  Determinants of resting cerebral blood flow in sickle cell disease.

Authors:  Adam M Bush; Matthew T Borzage; Soyoung Choi; Lena Václavů; Benita Tamrazi; Aart J Nederveen; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2016-07-04       Impact factor: 10.047

8.  BOLD delay times using group delay in sickle cell disease.

Authors:  Julie Coloigner; Chau Vu; Adam Bush; Matt Borzage; Vidya Rajagopalan; Natasha Lepore; John Wood
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-03-21

9.  Diminished cerebral oxygen extraction and metabolic rate in sickle cell disease using T2 relaxation under spin tagging MRI.

Authors:  Adam M Bush; Thomas D Coates; John C Wood
Journal:  Magn Reson Med       Date:  2017-12-01       Impact factor: 4.668

10.  Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia.

Authors:  Melanie E Fields; Kristin P Guilliams; Dustin Ragan; Michael M Binkley; Amy Mirro; Slim Fellah; Monica L Hulbert; Morey Blinder; Cihat Eldeniz; Katie Vo; Joshua S Shimony; Yasheng Chen; Robert C McKinstry; Hongyu An; Jin-Moo Lee; Andria L Ford
Journal:  Blood       Date:  2019-03-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.